» Articles » PMID: 30959238

Cyclodextrin-membrane Interaction in Drug Delivery and Membrane Structure Maintenance

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2019 Apr 9
PMID 30959238
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclodextrins (CDs) are cyclic oligosaccharides able to improve drug water solubility and stability by forming CD/drug inclusion complexes. To further increase drug entrapment and delay its release, the CD/drug inclusion complex can be embedded in the aqueous phase of a liposome, a lipid vesicle composed of phospholipid bilayer surrounding an aqueous compartment. The resulting carrier is known as drug-in-cyclodextrin-in-liposome (DCL) system. CDs and DCLs are recognized as effective drug delivery systems; therefore, understanding the interaction of CDs with liposomal and biological membranes is of great importance. CDs are able to extract phospholipids, cholesterol, and proteins from membranes; the effect depends on the membrane structure and composition as well as on the CD type and concentration. Under definite conditions, CDs can affect the membrane fluidity, permeability, and stability of liposomes and cells, leading to the leakage of some of their internal constituents. On the other side, CDs demonstrated their beneficial effects on the membrane structure, including preservation of the membrane integrity during freeze-drying. In this paper, we review the literature concerning the interaction of CDs with biomimetic and biological membranes. Moreover, the impact of CDs on the membrane properties, mainly fluidity, stability, and permeability, is highlighted.

Citing Articles

Cancer-Targeting Peptides Functionalized With Polyarginine Enables GRP78-Dependent Cell Uptake and siRNA Delivery Within the DU145 Prostate Cancer Cells.

Hilan G, Daniel G, Collak F, Sabatino D, Willmore W J Pept Sci. 2025; 31(3):e70007.

PMID: 39967318 PMC: 11836551. DOI: 10.1002/psc.70007.


An Advanced Combinatorial System from Leaves and Propolis Enhances Antioxidants' Skin Delivery and Fibroblasts Functionality.

Athanasopoulou S, Spanidi E, Panagiotidou E, Cavagnino A, Bobier A, Gardikis K Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770452 PMC: 11678553. DOI: 10.3390/ph17121610.


An aerosol nanocomposite microparticle formulation using rifampicin-cyclodextrin inclusion complexes for the treatment of pulmonary diseases.

Freeman M, Shen J, Meenach S Int J Pharm. 2024; 665:124755.

PMID: 39321902 PMC: 11464167. DOI: 10.1016/j.ijpharm.2024.124755.


Asymmetric Lipid Bilayers and Potassium Channels Embedded Therein in the Contact Bubble Bilayer.

Matsuki Y, Iwamoto M, Oiki S Methods Mol Biol. 2024; 2796:1-21.

PMID: 38856892 DOI: 10.1007/978-1-0716-3818-7_1.


Cyclodextrin derivatives decrease Transient Receptor Potential vanilloid 1 and Ankyrin 1 ion channel activation via altering the surrounding membrane microenvironment by cholesterol depletion.

Nehr-Majoros A, Erostyak J, Fenyvesi E, Szabo-Meleg E, Szocs L, Setalo Jr G Front Cell Dev Biol. 2024; 12:1334130.

PMID: 38481530 PMC: 10933000. DOI: 10.3389/fcell.2024.1334130.